Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx on...
FDA Recall #D-0559-2024 — Class II — May 30, 2024
Product Description
Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03
Reason for Recall
Failed Content Uniformity Specifications
Recalling Firm
Lupin Pharmaceuticals Inc. — Baltimore, MD
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
3,552 bottles
Distribution
Nationwide in the US
Code Information
Lot F201519, Expiry: November 2024
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated